Imunon’s interim Chief Financial Officer Jeffrey Church will retire effective July 1, 2026, and Josh Blacher will be appointed interim Chief Financial Officer effective the same date.
| IndividualJeffrey ChurchJosh Blacher | RoleInterim Chief Financial OfficerInterim Chief Financial Officer; principal financial officer and principal accounting officer | Type of ChangeRetirement (and transition to consultant)Appointment | Effective DateJuly 1, 2026July 1, 2026 | ReasonRetirement; departure without any disagreements with managementResult of Church’s retirement | Replacement InfoSuccessor: Josh BlacherNot disclosed | Background DetailsHeld interim CFO since January 2026; will continue as consultant under amended Consulting Agreement ($10,000 monthly retainer)Age 54; employee of Danforth since Sept 2022; Managing Partner of Columbus Circle Capital since Aug 2019; prior CFO roles at BullFrog AI (since Dec 2024), Inmed, Therapix, Galmed; senior roles at Teva, Deutsche Asset Management, Morgan Stanley; BA in Economics (Yeshiva), MBA Finance (Columbia) | Board/Committee Role ChangesNot disclosedNot disclosed |
Original SEC Filing:
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.